Dendritic cell vaccine made from your own tumor cells
Treatments studied
Part of Cancer clinical trials.
This Phase 2 study tests a personalized glioblastoma vaccine made from your own immune cells (collected by apheresis) and your own tumor material. It’s meant to help your immune system recognize and attack the cancer after standard chemotherapy and radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have glioblastoma confirmed by pathology (biopsy/surgery tissue test).
- Your tumor was “monofocal” (a single main tumor area) and nearly fully removed, leaving about 5 mL or less.
- You can do standard radiation plus chemotherapy (the Stupp regimen) as part of your treatment plan.
- You’re at least 18 and can sign consent for pre-screening and the trial.
- Your health status is adequate (Karnofsky 70% or ECOG 0–1).
- Blood/heart tests must be suitable, including screening infections and being able to safely collect immune cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your own tumor material, aiming to lower the chance cancer returns after surgery. It is for people whose rare cancers have been removed completely and who have no standard treatment available after surgery.
This trial tests a personalized vaccine made from your own immune cells to see if it can help treat glioblastoma. If you are currently getting standard treatments like surgery, chemo, and radiation, you may be able to join.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to treat glioblastoma that has come back after standard treatment. The vaccine is designed to help your immune system recognize and attack your tumor.
This trial tests a personalized vaccine (made from your own immune cells and tumor 'neoantigens') combined with the chemotherapy drug temozolomide for people with newly diagnosed glioblastoma. The goal is to see if adding the vaccine helps the immune system better fight the tumor.
This trial tests whether adding a personalized vaccine made from your own immune cells and tumor can help standard chemotherapy and radiation work better against glioblastoma. It is for patients who have already had surgery and are starting or have just finished their first round of chemoradiation.
This trial tests a personalized immune therapy made from your own cells (dendritic cells) that target a protein called survivin in glioblastoma. It's given after standard radiation and chemotherapy, and may help your immune system fight the cancer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.